PRI Drops Suit Against Top Two FCRF Staff; Gilden, Compton Accept “Partnership” Offers
In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt
NCI Amends FCRF RFP, Extends Deadline To Nov. 10
Caribbean Conference Reports Incidence Differences With U.S.
Malone Retires As NIH Deputy, Raub To Succeed Him
Eight Win ASCO Young Investigator Awards
Niccotine Reports As Aiding Metastasis
President, Congress, Cancer Letter Take Off
Trending Stories
- Trump executive order to “Make America Healthy Again” cites questionable data from Wuhan
White House cites paper in pay-to-play journal claiming that U.S. has highest age-standardized incidence rate of cancer - Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research
- “The Agency finds you are not fit…”
HHS notifications of firing add insult to injury